Login / Signup

Efficacy and Safety of ARRY-371797 in LMNA -Related Dilated Cardiomyopathy: A Phase 2 Study.

Calum A MacRaeMatthew R G TaylorLuisa MestroniJohn MosesEuan A AshleyMatthew T WheelerNeal K LakdawalaRay E HershbergerVictor SandorMichael E SaundersColleen OliverPatrice A LeeDaniel P Judge
Published in: Circulation. Genomic and precision medicine (2022)
URL: https://clinicaltrials.gov; Unique identifier: NCT02057341.
Keyphrases
  • open label
  • muscular dystrophy
  • double blind
  • randomized controlled trial
  • placebo controlled
  • drug induced
  • duchenne muscular dystrophy